Report Detail
Global Drugs for Irritable Bowel Syndrome Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4519342 |
- 06 March, 2023 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Drugs for Irritable Bowel Syndrome market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Drugs for Irritable Bowel Syndrome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Drugs for Irritable Bowel Syndrome market size and forecasts, in consumption value ($ Million), 2018-2029
Global Drugs for Irritable Bowel Syndrome market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Drugs for Irritable Bowel Syndrome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Drugs for Irritable Bowel Syndrome market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs for Irritable Bowel Syndrome
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs for Irritable Bowel Syndrome market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical Company Limited, Pfizer, Inc., Abbott Laboratories, Novartis AG and AstraZeneca PLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Drugs for Irritable Bowel Syndrome market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Alosetron
Lubiprostone
Linaclotide
Others
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Takeda Pharmaceutical Company Limited
Pfizer, Inc.
Abbott Laboratories
Novartis AG
AstraZeneca PLC
Ironwood Pharmaceuticals Inc. and Allergan Plc
Bausch Health Companies Inc.
GlaxoSmithKline, Plc.
Lexicon Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drugs for Irritable Bowel Syndrome product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drugs for Irritable Bowel Syndrome, with revenue, gross margin and global market share of Drugs for Irritable Bowel Syndrome from 2018 to 2023.
Chapter 3, the Drugs for Irritable Bowel Syndrome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Drugs for Irritable Bowel Syndrome market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Irritable Bowel Syndrome.
Chapter 13, to describe Drugs for Irritable Bowel Syndrome research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Drugs for Irritable Bowel Syndrome
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Drugs for Irritable Bowel Syndrome by Type
- 1.3.1 Overview: Global Drugs for Irritable Bowel Syndrome Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Drugs for Irritable Bowel Syndrome Consumption Value Market Share by Type in 2022
- 1.3.3 Alosetron
- 1.3.4 Lubiprostone
- 1.3.5 Linaclotide
- 1.3.6 Others
- 1.4 Global Drugs for Irritable Bowel Syndrome Market by Application
- 1.4.1 Overview: Global Drugs for Irritable Bowel Syndrome Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Drugs for Irritable Bowel Syndrome Market Size & Forecast
- 1.6 Global Drugs for Irritable Bowel Syndrome Market Size and Forecast by Region
- 1.6.1 Global Drugs for Irritable Bowel Syndrome Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Drugs for Irritable Bowel Syndrome Market Size by Region, (2018-2029)
- 1.6.3 North America Drugs for Irritable Bowel Syndrome Market Size and Prospect (2018-2029)
- 1.6.4 Europe Drugs for Irritable Bowel Syndrome Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Drugs for Irritable Bowel Syndrome Market Size and Prospect (2018-2029)
- 1.6.6 South America Drugs for Irritable Bowel Syndrome Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Drugs for Irritable Bowel Syndrome Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Takeda Pharmaceutical Company Limited
- 2.1.1 Takeda Pharmaceutical Company Limited Details
- 2.1.2 Takeda Pharmaceutical Company Limited Major Business
- 2.1.3 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.1.4 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
- 2.2 Pfizer, Inc.
- 2.2.1 Pfizer, Inc. Details
- 2.2.2 Pfizer, Inc. Major Business
- 2.2.3 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.2.4 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Pfizer, Inc. Recent Developments and Future Plans
- 2.3 Abbott Laboratories
- 2.3.1 Abbott Laboratories Details
- 2.3.2 Abbott Laboratories Major Business
- 2.3.3 Abbott Laboratories Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.3.4 Abbott Laboratories Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Abbott Laboratories Recent Developments and Future Plans
- 2.4 Novartis AG
- 2.4.1 Novartis AG Details
- 2.4.2 Novartis AG Major Business
- 2.4.3 Novartis AG Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.4.4 Novartis AG Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Novartis AG Recent Developments and Future Plans
- 2.5 AstraZeneca PLC
- 2.5.1 AstraZeneca PLC Details
- 2.5.2 AstraZeneca PLC Major Business
- 2.5.3 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.5.4 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 AstraZeneca PLC Recent Developments and Future Plans
- 2.6 Ironwood Pharmaceuticals Inc. and Allergan Plc
- 2.6.1 Ironwood Pharmaceuticals Inc. and Allergan Plc Details
- 2.6.2 Ironwood Pharmaceuticals Inc. and Allergan Plc Major Business
- 2.6.3 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.6.4 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Developments and Future Plans
- 2.7 Bausch Health Companies Inc.
- 2.7.1 Bausch Health Companies Inc. Details
- 2.7.2 Bausch Health Companies Inc. Major Business
- 2.7.3 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.7.4 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Bausch Health Companies Inc. Recent Developments and Future Plans
- 2.8 GlaxoSmithKline, Plc.
- 2.8.1 GlaxoSmithKline, Plc. Details
- 2.8.2 GlaxoSmithKline, Plc. Major Business
- 2.8.3 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.8.4 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 GlaxoSmithKline, Plc. Recent Developments and Future Plans
- 2.9 Lexicon Pharmaceuticals, Inc.
- 2.9.1 Lexicon Pharmaceuticals, Inc. Details
- 2.9.2 Lexicon Pharmaceuticals, Inc. Major Business
- 2.9.3 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.9.4 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Lexicon Pharmaceuticals, Inc. Recent Developments and Future Plans
- 2.10 Sucampo Pharmaceuticals, Inc.
- 2.10.1 Sucampo Pharmaceuticals, Inc. Details
- 2.10.2 Sucampo Pharmaceuticals, Inc. Major Business
- 2.10.3 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Solutions
- 2.10.4 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Sucampo Pharmaceuticals, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Drugs for Irritable Bowel Syndrome Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Drugs for Irritable Bowel Syndrome by Company Revenue
- 3.2.2 Top 3 Drugs for Irritable Bowel Syndrome Players Market Share in 2022
- 3.2.3 Top 6 Drugs for Irritable Bowel Syndrome Players Market Share in 2022
- 3.3 Drugs for Irritable Bowel Syndrome Market: Overall Company Footprint Analysis
- 3.3.1 Drugs for Irritable Bowel Syndrome Market: Region Footprint
- 3.3.2 Drugs for Irritable Bowel Syndrome Market: Company Product Type Footprint
- 3.3.3 Drugs for Irritable Bowel Syndrome Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Drugs for Irritable Bowel Syndrome Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Drugs for Irritable Bowel Syndrome Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Drugs for Irritable Bowel Syndrome Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Drugs for Irritable Bowel Syndrome Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Drugs for Irritable Bowel Syndrome Consumption Value by Type (2018-2029)
- 6.2 North America Drugs for Irritable Bowel Syndrome Consumption Value by Application (2018-2029)
- 6.3 North America Drugs for Irritable Bowel Syndrome Market Size by Country
- 6.3.1 North America Drugs for Irritable Bowel Syndrome Consumption Value by Country (2018-2029)
- 6.3.2 United States Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 6.3.3 Canada Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Drugs for Irritable Bowel Syndrome Consumption Value by Type (2018-2029)
- 7.2 Europe Drugs for Irritable Bowel Syndrome Consumption Value by Application (2018-2029)
- 7.3 Europe Drugs for Irritable Bowel Syndrome Market Size by Country
- 7.3.1 Europe Drugs for Irritable Bowel Syndrome Consumption Value by Country (2018-2029)
- 7.3.2 Germany Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 7.3.3 France Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 7.3.5 Russia Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 7.3.6 Italy Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Drugs for Irritable Bowel Syndrome Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Drugs for Irritable Bowel Syndrome Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Drugs for Irritable Bowel Syndrome Market Size by Region
- 8.3.1 Asia-Pacific Drugs for Irritable Bowel Syndrome Consumption Value by Region (2018-2029)
- 8.3.2 China Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 8.3.3 Japan Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 8.3.5 India Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 8.3.7 Australia Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Drugs for Irritable Bowel Syndrome Consumption Value by Type (2018-2029)
- 9.2 South America Drugs for Irritable Bowel Syndrome Consumption Value by Application (2018-2029)
- 9.3 South America Drugs for Irritable Bowel Syndrome Market Size by Country
- 9.3.1 South America Drugs for Irritable Bowel Syndrome Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Drugs for Irritable Bowel Syndrome Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Drugs for Irritable Bowel Syndrome Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Drugs for Irritable Bowel Syndrome Market Size by Country
- 10.3.1 Middle East & Africa Drugs for Irritable Bowel Syndrome Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
- 10.3.4 UAE Drugs for Irritable Bowel Syndrome Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Drugs for Irritable Bowel Syndrome Market Drivers
- 11.2 Drugs for Irritable Bowel Syndrome Market Restraints
- 11.3 Drugs for Irritable Bowel Syndrome Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Drugs for Irritable Bowel Syndrome Industry Chain
- 12.2 Drugs for Irritable Bowel Syndrome Upstream Analysis
- 12.3 Drugs for Irritable Bowel Syndrome Midstream Analysis
- 12.4 Drugs for Irritable Bowel Syndrome Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Drugs for Irritable Bowel Syndrome. Industry analysis & Market Report on Drugs for Irritable Bowel Syndrome is a syndicated market report, published as Global Drugs for Irritable Bowel Syndrome Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Drugs for Irritable Bowel Syndrome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
